Clinical Trial Analytics

Accelerate Clinical Results and Speed New Therapies to Market

Transforming Clinical Trials with Data-Driven Efficiency

In today’s health innovation landscape, accelerating clinical trials safely and effectively is essential for bringing new therapies to patients faster. Instem’s Clinical Trial Analytics solutions streamline data analysis, optimize compliance, reduce reliance on internal IT, and promote transparency, enabling life sciences organizations to improve research efficiency while meeting regulatory demands. With tools that support secure data access and enhance team productivity, Instem empowers organizations to advance new drug products more rapidly and effectively.

Why Clinical Trial Analytics Solutions Are Essential

$

Ensuring Accessible, Compliant Data for Swift Decision-Making

Efficient data access and compliance are key to rapid trial progress. Instem’s solutions help research teams meet regulatory standards from initial data capture to final submission. By reducing bottlenecks, Instem’s solutions empower teams to maintain data integrity, optimize workflows, and bring therapies to market faster.

Solution Highlight: Accel™, Instem’s cloud-based and validated Statistical Computing Environment, provides a scalable, compliant solution for data analysis and data sharing. Equipped with all the biostats tools needed for clinical data analysis, Accel enables streamlined collaboration and rapid data insights, fostering quicker, better-informed decisions.

$

Enhancing Workflow Efficiency to Support Speed-to-Market

Clinical trial success depends on effective workflows and collaboration. Instem’s Clinical Trial Analytics suite centralizes data and processes, promoting cross-functional collaboration and reducing time spent on data preparation and regulatory compliance. This integration reduces errors, improves workflows, and supports faster study completions, helping organizations shorten their time to market.

Solution Highlight: Aspire is a modular analytics workbench that supports scalable, compliant data processing in a secure cloud environment. Perfect for top biotech organizations, the flexibility Aspire™ offers enables large teams to conduct efficient analyses, streamline workflows, and quickly adapt to evolving trial requirements.

$

Promoting Transparency and Safe Data Sharing for Global Compliance

Data privacy is essential for secure clinical trial transparency, particularly in global markets. Instem’s solutions allow organizations to anonymize and share data securely, meeting privacy regulations across regions. With these tools, research organizations can share data confidently, ensuring global regulatory compliance and supporting transparent drug development processes.

Solution Highlight: Blur™ is Instem’s anonymization software designed for clinical data de-identification, anonymization, and risk assessment. Leveraging NLP and a robust risk assessment engine, Blur ensures compliant data sharing, allowing sponsors to meet regulatory requirements and confidently engage in data-sharing initiatives.

Instem’s Suite of Clinical Trial Analytics Solutions

Instem’s Clinical Trial Analytics suite includes tools that accelerate timelines and support compliance. Each solution is designed to help research organizations efficiently bring new products to market, from cloud-based and validated data environments to data anonymization.

Accel™

Accel is a cloud-based and validated SCE that supports secure programming and data analysis. With numerous pre-configured tools, Accel enables quick and secure access to data insights, supporting faster collaboration and decision-making for accelerated drug development.

Aspire™

Aspire offers a cloud-first analytics platform that enables flexible, compliant data processing. Designed for large clinical trial teams, Aspire provides the scalability needed for unique clinical trial workflows, helping teams maintain agility in a secure and compliant framework.

$

Blur™

Blur is Instem’s dedicated software for bulk anonymizing clinical data and documents. With advanced NLP capabilities and risk assessment, Blur enables organizations to meet global data-sharing compliance requirements without compromising patient privacy, accelerating clinical trial transparency and market readiness.

$

Clinical Trial Transparency Services

Instem’s on-demand transparency services help organizations anonymize data and meet public disclosure requirements for faster market access. These services support efficient data sharing while safeguarding regulatory compliance across regions.

$

Selecting the Right Clinical Trial Analytics and Transparency Solution

Instem’s Clinical Trial Analytics and Transparency suites are tailored to accelerate clinical trial timelines, ensure compliance, and support transparent data sharing. Whether your organization needs cloud-based analytics, advanced anonymization, or strategic consulting, our solutions are built to adapt to complex clinical research environments and evolving compliance standards.

Success Stories: Real-World Impact with Instem’s Clinical Trial Analytics and Transparency Solutions

Research teams worldwide rely on Instem’s solutions to optimize workflow efficiency, ensure regulatory compliance, and bring therapies to market faster. Clients report significant reductions in clinical trial completion times and enhanced data integrity, demonstrating Instem’s impact in accelerating drug development.

Resources and Support for Clinical Trial Analytics and Transparency

Instem provides resources, including guides, training, and expert support, to help research teams maximize their clinical trial analytics and transparency tools. Our dedicated support services equip teams with the knowledge to achieve faster, compliant clinical trial outcomes.

Get Started with Instem’s Clinical Trial Analytics and Transparency Solutions

Ready to accelerate your clinical trial timelines? Schedule a personalized demo of Instem’s clinical trial analytics and transparency tools and discover how our suite supports efficient, compliant clinical research.

Donna Robinson

Chief Commercial Officer